Vladimir Yu. Ul'YAnov

Vladimir Yu. Ul'YAnov

Auto-generated profile, based on publicly available information

Vladimir Yu. Ul'YAnov

Saratov State Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Alexey V. ErmakovAlexey V. Ermakov
Alexey V. Ermakov
RVRoman Verkhovskii
Roman Verkhovskii
IBIrina V. Babushkina
Irina V. Babushkina
Daria TrushinaDaria Trushina
Daria Trushina
OIOlga A. Inozemtseva
Olga A. Inozemtseva
MAMaria N. Antipina
Maria N. Antipina
Microencapsulation and targeted delivery of cytotoxic and antibacterial agents of photodynamic therapy (PDT) improve the treatment outcomes for infectious diseases and cancer. In many cases, the loss of activity, poor encapsulation efficiency, and inadequate drug dosing hamper the success of this strategy. Therefore, the development of novel and reliable microencapsulated drug formulations granting high efficacy is of paramount importance. Here we report the in vitro delivery of a water-soluble cationic PDT drug, zinc phthalocyanine choline derivative (Cholosens), by biodegradable microcapsules assembled from dextran sulfate (DS) and poly-l-arginine (PArg). A photosensitizer was loaded in pre-formed [DS/PArg]4 hollow microcapsules with or without exposure to heat. Loading efficacy and drug release were quantitatively studied depending on the capsule concentration to emphasize the interactions between the DS/PArg multilayer network and Cholosens. The loading data were used to determine the dosage for heated and intact capsules to measure their PDT activity in vitro. The capsules were tested using human cervical adenocarcinoma (HeLa) and normal human dermal fibroblast (NHDF) cell lines, and two bacterial strains, Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli. Our results provide compelling evidence that encapsulated forms of Cholosens are efficient as PDT drugs for both eukaryotic cells and bacteria at specified capsule-to-cell ratios.

25 May 2021 in Izvestiya of Saratov University. New Series. Series: Mathematics. Mechanics. Informatics
Verified
Journal Article
Closed access
SUSaratov State University
Saratov State University
LBL. V. Bessonov
L. V. Bessonov
AGA. A. Golyadkina
A. A. Golyadkina
PDP. O. Dmitriev
P. O. Dmitriev
ADA. V. Dol
A. V. Dol
AKA. V. Kharlamov
A. V. Kharlamov

15 December 2023 in The European Physical Journal Special Topics
Verified
Journal Article
Closed access
PDF file
VUVladimir Ulyanov
Vladimir Ulyanov
MZM. O. Zhuravlev
M. O. Zhuravlev
Anton R KiselevAnton R Kiselev
Anton R Kiselev
VMVyacheslav Musatov
Vyacheslav Musatov
TMTatiyana Musatova
Tatiyana Musatova
Anastasiya RunnovaAnastasiya Runnova
Anastasiya Runnova

10 October 2022 in Journal of Medical and Biological Research
Verified
Journal Article
Closed access
EGElena A. Galashina
Elena A. Galashina
VUV.I. Razumovsky Saratov State Medical University
V.I. Razumovsky Saratov State Medical University
ЕGЕkaterina V. Gladkova
Еkaterina V. Gladkova
VUVladimir Yu. Ul’yanov
Vladimir Yu. Ul’yanov
The heterogeneity of osteoarthritis pathogenesis is determined by combinations of various parameters indicating the degree of joint degradation at the early stages of the disease. Subchondral bone metabolism markers in body fluids can indicate pathological degenerative processes in the articular tissue. The role of inflammatory factors in the development of articular damage in osteoarthritis is widely discussed in modern literature. In this regard, the purpose of the review was to analyse the data of Russian and foreign scientific literature on the pathogenetic role of subchondral remodelling and immune inflammation factors in early manifestations of primary osteoarthritis in larger joints. The scientific studies of 2015–2022 were retrieved from Medline, PubMed, Free Medical Journals, еLIBRARY, PubMed Central archives, as well as using Google and SpringerLink platforms, and Elsevier. The following keywords were searched for both in Russian and in English: primary osteoarthritis, early stages, subchondral remodelling, bone resorption markers, bone tissue formation markers, cytokines, interleukins, chemokines, anabolic growth factors, RANKL. The analysis revealed that bone resorption and formation markers, representing the tumour necrosis factor superfamily, a number of interleukins, chemokines, and anabolic growth factors can be involved in the pathogenesis of early manifestations of primary osteoarthritis in larger joints. The literature review suggests that subchondral bone remodelling is important in the pathogenesis of incipient osteoarthritis, whose main metabolic aspects can be objectified through biochemical markers identified in body fluids and joint tissues.

16 July 2023 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
SBSvetlana V. Belova
Svetlana V. Belova
RZRoman A. Zubavlenko
Roman A. Zubavlenko
EGEkaterina V. Gladkova
Ekaterina V. Gladkova
IBIrina V. Babushkina
Irina V. Babushkina
VUVladimir Yu. Ul'YAnov
Vladimir Yu. Ul'YAnov
УЮУльянов Владимир Юрьевич
Ульянов Владимир Юрьевич
INTRODUCTION: Posttraumatic osteoarthrosis (PTOA) resulting from injuries of connective-tissue components of the joint, is accompanied by formation of free radicals activating chondro- and osteoresorption, which leads to fragmentation of biopolymers of the extracellular matrix of the joint tissues. AIM: To study the peculiarities of free radical oxidation and metabolic processes of cartilage and bone tissues in animals with a surgical model of PTOA of the knee joint. MATERIALS AND METHODS: The study was conducted on 31 rats (11 intact animals and 20 animals with PTOA model). The metabolic processes of the connective tissue were evaluated by the changes in the content of biomarkers of the cartilage (hyaluronan, aggrecan) and bone (fibroblast growth factor-23, osteprotegerin, sclerostin, osteocalcin) tissues. The condition of the free radical oxidation processes was evaluated by the level of lipid hydroperoxides, and the activity of antioxidant system by the parameters of the total antioxidant and thiol statuses. RESULTS: In rats with the PTOA model, an increase in cartilage tissue biopolymers aggrecan and hyaluronan (p 0.001) was noted with a negative change in the marker of bone formation (a tendency to increase in the content of osteocalcin) and markers of regulation of bone homeostasis (increased fibroblast growth factor-23, p 0.001), with a tendency to decrease in the content of osteoprotegerin and sclerostin, in comparison with intact animals of the control group. In parallel with this, an increase in lipid hydroperoxides (p 0.01) in the systemic bloodstream was detected with a decrease in the thiol status index (p 0.01) with preserved normal total antioxidant activity (p 0.05). CONCLUSION: The data of the conducted study evidences intensification of free radical oxidation and derangement of metabolic processes in the bone and cartilage tissues in animals with a surgical model of PTOA of the knee joint. A negative change in the metabolism of the bone tissue was manifested by the loss of balance of remodeling processes, and metabolic disorders in the cartilage tissue consisted in the destruction of its biopolymers in conditions of intensification of free radical oxidation processes and relative tension of the thiol system with the total antioxidant activity remaining within the physiological norm. The established facts are promising from the point of view of using the studied biomarkers both for the identification of pathogenetic triggers of PTOA of the knee joint, and for the determination of the direction of therapeutic measures.

25 May 2021 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
SBS. V. Belova
S. V. Belova
EGE. V. Gladkova
E. V. Gladkova
RZR. A. Zubavlenko
R. A. Zubavlenko
VUV. Yu. Ulyanov
V. Yu. Ulyanov
ВУВ. Ю. Ульянов
В. Ю. Ульянов
СИСТЕМНЫЕ ПРОЯВЛЕНИЯ ПЕРВИЧНОГО ОСТЕОАРТРОЗА КОЛЕННЫХ СУСТАВОВ У ПАЦИЕНТОВ НА РАННЕЙ СТАДИИ ЕГО РАЗВИТИЯ